The FDA has just put up all the materials related to Friday's meeting of the Reproductive Health Drugs Advisory Committee on Flibanserin (in case you're wondering, Flibanserin is not related to reproduction, but the FDA doesn't have a Sexual Pleasure Drugs Advisory Committee, at least not yet!).
Several members of the New View Campaign have been doing an excellent job keeping the rest of us up to date on what's happening. They'll be at the hearing both to testify and also to tweet it live from Maryland.
You can follow their twitter feed here.
You can download the briefing from Boehringer-Ingelheim, as well as the agenda and names of the committee members here.
And if you're interested in really digging in, here is the full Boehringer-Ingelheim application for Flibanserin (all 248 pages of it), which includes tons of data we've been waiting to see.
|| Twitter | Newsletter Signup | Sexuality Forum ||